Patent Assignment
Reel/Frame 075425/0001
Change of Name
Recorded: 2026-04-17
Pages: 8
Assignor
SHIRE VIROPHARMA INCORPORATED
Executed: 2019-12-20
Assignee
SHIRE VIROPHARMA LLC
300 SHIRE WAY, LEXINGTON, MASSACHUSETTS, 02421
Covered Property
(1)
Crystalline Phases of 5,6-Dichloro-2-(Isopropylamino)-(1 Beta-L-Ribofuranosyl)1H-Benzimidazole
Application:
19/016,496 →
Publication:
US US20250145653A1
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Apr 17, 2026
From: VIROPHARMA INCORPORATED
To: SHIRE VIROPHARMA INCORPORATED
Reel/Frame 075459/0121 →
Assignment of Assignor's Interest
Apr 17, 2026
From: COQUEREL, GERALD; LEVILAIN, GUILLAUME; PETIT, MARIE-NOELLE; COSTE-LECONTE, SERVANTE
To: VIROPHARMA INCORPORATED
Reel/Frame 074402/0727 →
Assignment of Assignor's Interest
Apr 17, 2026
From: SHIRE VIROPHARMA LLC
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 074402/0915 →